Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

Gene Therapy

Volumn 17, Issue 6, 2010, Pages 811-814

  Gill, H S ^a,d   Soderholm J ^b,e   Prausnitz, M R ^a,c   Sallberg M ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Georgia Institute of Technology   (United States)

^d Department of Electrical and Computer Engineering   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cellular immune response; DNA vaccine; DNA coated microneedle; Hepatitis C virus; Microfabricated needle

Indexed keywords

DNA VACCINE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; GENE GUN; HEPATITIS C; MATERIAL COATING; MICRONEEDLE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; SKIN; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; HEPACIVIRUS; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; MICROINJECTION; MOUSE;

ADMINISTRATION, CUTANEOUS; ANIMALS; HEPACIVIRUS; MICE; MICE, INBRED BALB C; MICROINJECTIONS; NEEDLES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

HEPATITIS C VIRUS;

EID: 77953479878     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.22     Document Type: Article

References (18)

1. Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. DNA vaccines for biodefence. Adv Drug Deliver Rev 2005; 57: 1343-1361.
2. Donnelly J, Berry K, Ulmer JB. Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 2003; 33: 457-467.
3. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7: 1201-1214.
4. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Micro-needle-based vaccines. Curr Top Microbiol Immunol 2009; 333: 369-393.
5. Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 2009; 4: e4773.
6. Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 2006; 24: 1653-1664.
7. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromecha-nical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 2002; 8: 415-419.
8. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009; 27: 454-459.
9. Hooper JW, Golden JW, Ferro AM, King AD. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007; 25: 1814-1823.
10. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release 2007; 117: 227-237.
11. Ahlen G, Soderholm J, Tjelle T, Kjeken R, Frelin L, Hoglund U et al. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol 2007; 179: 4741-4753.
12. Frelin L, Alheim M, Chen A, Soderholm J, Rozell B, Barnfield C et al. Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Therapy 2003; 10: 686-699.
13. Fuller DH, Loudon P, Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 2006; 40: 86-97.
14. Frelin L, Ahlen G, Alheim M, Weiland O, Barnfield C, Liljestrom P et al. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus non-structural 3/4A gene. Gene Therapy 2004; 11: 522-533.
15. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain 2008; 24: 585-594.
16. Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008; 105: 2058-2063.
17. Cho JH, Youn JW, Sung YC. Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization. J Immunol 2001; 167: 5549-5557.
18. Gill HS, Prausnitz MR. Coating formulations for microneedles. Pharm Res 2007; 24: 1369-1380.